Submit your Manuscript
  • info@jjgastro.com
  • ISSN 3065-5498
Submit your Manuscript

Journal of Gastroenterology Research and Practice

Impact Factor (IF) value: 1.2, ISSN 3065-5498

Gastroenterology is the branch of medicine dealing with the digestive system and disorders. Physicians practicing in this field are called Gastroenterologists. Journal of Gastroenterology Research and Practice is an international open access journal publishing latest research on different areas of Gastroenterology, Hepatology and Digestive System.

Journal of Gastroenterology Research and Practice provides free and unlimited access to the readers following open access model of publication. Journal accept all kinds of Manuscripts: Research, Review, Case Report, Clinical Image, Short Communication, Editorial, Commentaries, Review opinion, Brief notes etc. All the received manuscripts are assigned to handling editor and two external reviewers for improving the quality of the material.

Editorial Board

Toshio Yamaguchi

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo Bunkyo-ku, Tokyo, Japan.

Xiang-Lei Yuan

Department of Gastroenterology, West China Hospital, Sichuan University, No. 37 Guo Xue Xiang, Chengdu, 610041, Sichuan, China.

Yingtai Chen

Department of Abdominal Surgical Oncology, Cancer Hospital/Institute China Academy of Medical Sciences, China National Cancer Center, Beijing, China.

Rou Zhang

Institution of Hepatology, First Affiliated Teaching Hospital, SOM, Xi'an Jiaotong University, Xi'an City, China.

Marzocchi Guido

University of Bologna Sant'Orsola-Malpighi Hospital: Bologna, Emilia-Romagna, Italy.

Triantafyllou Tania

Department of Surgery, Hippocration Hospital, University of Athens, Greece.

Jang Ho Cho

Clinical associate professor, Division of Oncology, Department of Internal Medicine , Incheon St. Mary's Hospital, The Catholic University of Korea, Korea.

Huang Wen-Kuan

Karolinska University Hospital, Division of Hematology-Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan

Latest Articles

Effect of tryptophan restriction in the therapy of irritable bowel syndrome: A systematic review

www.doi.org/10.52768/jjgastro/1214

The metabolic pathways of Tryptophan (TRP) have been implicated in the pathophysiology of Irritable Bowel Syndrome (IBS), positing that the strategic modulation of TRP consumption may exert regulatory effects on serotonin levels, consequently altering the clinical manifestation of IBS.

Pneumatosis intestinalis

www.doi.org/10.52768/jjgastro/1215

Pneumatosis intestinalis is a rare condition characterized by the presence of gas bubbles within the mucosa of the gastrointestinal tract. This article presents the case of a woman who showed significant improvement following conservative treatment.

Gastric mucormycosis post COVID-19

Mucormycosis is a serious disease caused by fungi of the Mucorales order Mucorales. The main risk factors of mucormycosis include diabetes mellitus, phagocyte deficiency, corticosteroid use and organ or stem cell transplantation. More recently, COVID-19 has become a risk factor described in some case reports, increasing the importance of diagnostic suspicion in patients with COVID-19 and clinical signs compatible with mucormycosis.

A therapeutic dilemma on lupus enteritis with bowel ischemia in a filipino female

Lupus enteritis is rare and life-threatening. It is a differentia among patients with Systemic Lupus Erythematosus (SLE) with severe abdominal pain. To our knowledge, this is the first locally reported case to date. A high index of suspicion and immediate treatment are necessary due to its high mortality rate and poor prognosis.